Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Surgery, gynecology & obstetrics

• Publication date

  1988-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 2460958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.

  1986cited by this paper
• Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.

  1986cited by this paper
• Neurotensin increases colonic motility.

  1986cited by this paper
• Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors.

  1986cited by this paper
• Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.

  1985cited by this paper
• A Radioimmunoassay for Circulating Human Proinsulin

  1985cited by this paper
• Role of neurotensin in pancreatic secretion.

  1984cited by this paper
• Pancreatic polypeptide inhibits exocrine pancreatic responses to six stimulants.

  1984cited by this paper
• Partial characterization of immunoreactive substance P in the rat pituitary gland.

  1984cited by this paper
• Bombesin-like immunoreactivity in human gastrointestinal tract.

  1984cited by this paper
• Pancreatic polypeptide release: role of stimulants of exocrine pancreatic secretion in dogs.

  1984cited by this paper
• Comparison of Four Provocative Tests for the Diagnosis of Gastrinoma

  1983cited by this paper
• Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.

  1983cited by this paper
• The development of motilin, cholecystokinin and vasoactive intestinal peptide immunoreactivity in the forebrain and hindbrain of the rat, as determined by radioimmunoassay.

  1983cited by this paper
• The intestinal phase of pancreatic polypeptide release.

  1982cited by this paper
• Hormone-stimulated release of pancreatic polypeptide before and after vagotomy in dogs.

  1981cited by this paper
• Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in the dog.

  1981cited by this paper
• Effect of neurotensin on gastric function in man.

  1980cited by this paper
• Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs.

  1980cited by this paper
• Calcium Infusion: A New Provocative Test for Insulinomas

  1979cited by this paper
• The influence of calcium on the basal and acetylcholine-stimulated secretion of pancreatic polypeptide.

  1979cited by this paper
• Effect of substance P on intestinal muscle.

  1978cited by this paper
• Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon.

  1976cited by this paper
• Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas.

  1976cited by this paper
• Surgical management of the Zollinger-Ellison syndrome.

  1974cited by this paper
• Suppressive effect of secretin upon pancreatic alpha cell function.

  1972cited by this paper
• The diagnostic value of sodium tolbutamide in hypoglycemic states.

  1961cited by this paper
• Primary Peptic Ulcerations of the Jejunum Associated with Islet Cell Tumors of the Pancreas

  1955cited by this paper

• Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia

  2023cites this paper
• [Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha].

  1996cites this paper
• Islet cell tumors of the pancreas.

  1995cites this paper
• Gastrointestinal neuroendocrine tumors.

  1994cites this paper
• Differential effects of LHRH and somatostatin analogs on human breast cancer.

  1992cites this paper
• Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.

  1992cites this paper
• Hypercalcemia due to hyperparathyroidism treated with a somatostatin analogue.

  1991cites this paper
• Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane.

  1991cites this paper
• Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.

  1990cites this paper
• The clinical use of somatostatin analogues in the treatment of cancer.

  1990cites this paper
• Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment.

  1990cites this paper
• Severe secretory diarrhea with elevated gastrin-releasing peptide controlled by somatostatin analogue: a case report.

  1990cites this paper
• Anaesthetic literature

  1989cites this paper